Application 074738
- Type
- ANDA
- Sponsor
- ACTAVIS MID ATLANTIC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ACYCLOVIR | ACYCLOVIR | SUSPENSION;ORAL | 200MG/5ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0472-0082 | Acyclovir | Acyclovir | Actavis Pharma, Inc. | ANDA | Current |
| 0472-0082 | Acyclovir | Acyclovir | Actavis Pharma, Inc. | ANDA | Current |
| 17856-0083 | Acyclovir | Acyclovir | ATLANTIC BIOLOGICALS CORP. | ANDA | Current |
| 17856-0083 | Acyclovir | Acyclovir | ATLANTIC BIOLOGICALS CORP. | ANDA | Current |
| 17856-0083 | Acyclovir | Acyclovir | ATLANTIC BIOLOGICALS CORP. | ANDA | Current |
| 68788-9783 | Acyclovir | Acyclovir | Preferred Pharmaceuticals, Inc. | ANDA | Current |